1. Filaggrin loss‐of‐function mutations and incident cancer: a population‐based study. (1st December 2014) Authors: Skaaby, T.; Husemoen, L.L.N.; Thyssen, J.P.; Meldgaard, M.; Thuesen, B.H.; Pisinger, C.; Jørgensen, T.; Carlsen, K.; Johansen, J.D.; Menné, T.; Szecsi, P.B.; Stender, S.; Linneberg, A. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Filaggrin loss‐of‐function mutations and incident cancer: a population‐based study. (9th November 2014) Authors: Skaaby, T.; Husemoen, L.L.N.; Thyssen, J.P.; Meldgaard, M.; Thuesen, B.H.; Pisinger, C.; Jørgensen, T.; Carlsen, K.; Johansen, J.D.; Menné, T.; Szecsi, P.B.; Stender, S.; Linneberg, A. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Individuals with complete filaggrin deficiency may have an increased risk of squamous cell carcinoma. (1st June 2014) Authors: Kaae, J.; Szecsi, P.B.; Meldgaard, M.; Espersen, M.L.M.; Stender, S.; Johansen, J.D.; Bandier, J.; Thyssen, J.P.; Menné, T.; Nielsen, S.L.; Høgdall, E.; Balslev, E.; Skov, L. Journal: British journal of dermatology Issue: Volume 170:Number 6(2014:Jun.) Page Start: 1380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Individuals with complete filaggrin deficiency may have an increased risk of squamous cell carcinoma. (June 2014) Authors: Kaae, J.; Szecsi, P.B.; Meldgaard, M.; Espersen, M.L.M.; Stender, S.; Johansen, J.D.; Bandier, J.; Thyssen, J.P.; Menné, T.; Nielsen, S.L.; Høgdall, E.; Balslev, E.; Skov, L. Journal: British journal of dermatology Issue: Volume 170:Number 6(2014:Jun.) Page Start: 1380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗